International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2026.2604010

Proceedings Articles, ID 952

Accurate Diagnosis of Prostate Cancer via Magnetic-Optical Dual-Modal Imaging Based on Dual-Target Probes

Main Article Content

Wenjie Zhao (Beihang yuiversity), Yu An (1) School of Engineering Medicine & School of Biological Science and Medicine Engineering, Beihang University, Beijing, China; 2) The Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology of China, Beijing, China)

Copyright (c) 2026 Wenjie Zhao, Yu An

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The heterogeneous expression of PSMA, the primary PCa biomarker, contributes to significant underdiagnosis. Here, we developed a dual-targeted probe (MNP@FITC-WTN/Dye800CW-D7) against PSMA and TFR to enable precise PCa diagnosis. Our probe exhibited enhanced tumor retention and a superior response rate over control groups.

Article Details

References

[1]GFilho AM, Laversanne M, Ferlay J, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. International journal of cancer.2025;156(7):1336-1346.
[2]Fang J, Alhaskawi A, Dong Y, et al. Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer. Journal of Zhejiang University. Science. B. 2025;26(2):124-144.
[3]Sayar E, Patel RA, Coleman IM, et al. Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer. JCI Insight. 2023;8(7):e162907.
[4]Lu C, Han L, Wang J, Wan J, Song G, Rao J. Engineering of magnetic nanoparticles as magnetic particle imaging tracers. Chemical Society reviews. 2021;50(14):8102-8146.

Most read articles by the same author(s)